From the past, a long way to future challenges for a greater control of tuberculosis

S. Villa, N. Riccardi, D. Canetti, R. Alagna, P. Castellotti, M. Ferrarese, D. Cirillo, I. Barberis, N.L. Bragazzi, V. Gazzaniga, V. Ricucci, L.R. Codecasa, G. Besozzi, M. Martini

Research output: Contribution to journalArticlepeer-review

Abstract

Tuberculosis (TB) and humans have coexisted for more than 40,000 years; however TB remains a global threat to human kind. The international community has developed new tools for early detection, but TB strains evolved acquiring resistance to first-line therapeutic drugs with increasing treatment challenges. Furthermore, TB has formed also an alliance with human immunodeficiency virus; in this way the poorest populations are most affected. The current vaccine planning activity includes 14 new vaccines against TB (11 of those in the phaseII/III) developed with different techniques. Now, more than ever, new anti-TB drugs and new anti-TB regimens are urgently required as well as universal health care and social protection in order to tackle down both hard to treat TB and the social determinants of TB. Coordinated actions and sharing of information are needed to aspire everywhere to the best clinical practices and improve quality of life of patients and their families. © 2020
Original languageEnglish
JournalTuberculosis
Volume123
DOIs
Publication statusPublished - 2020

Keywords

  • End TB
  • Evolution of TB
  • Future challenges
  • Past
  • Tuberculosis
  • BCG vaccine
  • Article
  • BCG vaccination
  • human
  • latent tuberculosis
  • nonhuman
  • priority journal
  • quality of life
  • tuberculosis
  • tuberculosis control

Fingerprint

Dive into the research topics of 'From the past, a long way to future challenges for a greater control of tuberculosis'. Together they form a unique fingerprint.

Cite this